If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Etsuro Nanishi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Mucocutaneous Lymph Node Syndrome Medicine & Life Sciences
Calcitonin Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences
Blood Coagulation Factor Inhibitors Medicine & Life Sciences
Central Nervous System Bacterial Infections Medicine & Life Sciences
Coronary Aneurysm Medicine & Life Sciences
Drug Hypersensitivity Syndrome Medicine & Life Sciences
Protein S Deficiency Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 70 Citations
  • 5 h-Index
  • 17 Article
  • 1 Letter
  • 1 Review article

A Nationwide Survey of Pediatric-onset Japanese Encephalitis in Japan

Nanishi, E., Hoshina, T., Sanefuji, M., Kadoya, R., Kitazawa, K., Arahata, Y., Sato, T., Hirayama, Y., Hirai, K., Yanai, M., Nikaido, K., Maeda, A., Torisu, H., Okada, K., Sakai, Y. & Ohga, S., Jun 2019, In : Clinical Infectious Diseases. 68, 12, p. 2099-2104 6 p., ciy816.

Research output: Contribution to journalReview article

Japanese Encephalitis
Japan
Japanese Encephalitis Vaccines
Pediatrics
Japanese Encephalitis Virus

Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease

Oda, T., Nagata, H., Nakashima, Y., Nanishi, E., Takada, Y., Nishimura, M., Kubo, E., Hatae, K. & Ohga, S., Nov 2019, In : Journal of Pediatrics. 214, p. 227-230 4 p.

Research output: Contribution to journalArticle

Mucocutaneous Lymph Node Syndrome
Intravenous Immunoglobulins
Fever
Therapeutics

Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease

Nakashima, Y., Nanishi, E., Yamamura, K., Uike, K., Terashi, E., Hirata, Y., Nagata, H., Morihana, E., Tanaka, T., Honjo, S., Takada, H. & Ohga, S., Feb 2019, In : Cytokine. 114, p. 26-31 6 p.

Research output: Contribution to journalArticle

Mucocutaneous Lymph Node Syndrome
Calcitonin
Immunoglobulins
Intravenous Immunoglobulins
Serum
2 Citations (Scopus)

Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease

Nagatomo, Y., Muneuchi, J., Nakashima, Y., Nanishi, E., Shirozu, H., Watanabe, M., Uike, K., Nagata, H., Hirata, Y., Yamamura, K., Takahashi, Y., Okada, S., Suzuki, Y., Hasegawa, S. & Ohga, S., Nov 15 2018, In : International Journal of Cardiology. 271, p. 317-321 5 p.

Research output: Contribution to journalArticle

Coronary Aneurysm
Mucocutaneous Lymph Node Syndrome
Coronary Vessels
Therapeutics
Infliximab
1 Citation (Scopus)

Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: A phase 2, open-label, randomized control study

Nanishi, E., Nishio, H., Takada, H., Yamamura, K., Fukazawa, M., Furuno, K., Mizuno, Y., Saigo, K., Kadoya, R., Ohbuchi, N., Onoe, Y., Yamashita, H., Nakayama, H., Hara, T., Ohno, T., Takahashi, Y., Hatae, K., Harada, T., Shimose, T., Kishimoto, J. & 2 others, Ohga, S. & Hara, T., Jul 1 2017, In : Journal of the American Heart Association. 6, 7, e005370.

Research output: Contribution to journalArticle

Mucocutaneous Lymph Node Syndrome
Passive Immunization
Clarithromycin
Intravenous Immunoglobulins
Recurrence